Picture of Biogaia AB logo

BIOG B Biogaia AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Annual cashflow statement for Biogaia AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line254361443423412
Depreciation
Non-Cash Items0.047-9.1-1.4847.68.83
Unusual Items
Other Non-Cash Items
Changes in Working Capital-59.1-57.3-40.9-123-139
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities222319426373307
Capital Expenditures-6.38-17.9-48.6-14.2-3.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-121-0.225-2.370.080.256
Acquisition of Business
Sale of Fixed Assets
Purchase of Investments
Cash from Investing Activities-127-18.1-50.9-14.1-3.34
Financing Cash Flow Items-2.8-2.9-4.4-4.4-5
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-81.8-314-308-690-710
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash16.83.6955.8-320-423